Search

Your search keyword '"McCormick TS"' showing total 153 results

Search Constraints

Start Over You searched for: Author "McCormick TS" Remove constraint Author: "McCormick TS"
153 results on '"McCormick TS"'

Search Results

1. Current knowledge on psoriasis and autoimmune diseases

2. Case report of individual with cutaneous immunodeficiency and novel 1p36 duplication

3. The Probiotic BIOHM Improves Nutrient Absorption by Disrupting Gastrointestinal Biofilms

5. A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis.

7. Analysis of Gut Bacterial and Fungal Microbiota in Children with Autism Spectrum Disorder and Their Non-Autistic Siblings.

8. Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.

9. Maximizing the potential of biobanks in dermatology research.

10. A Probiotic Amylase Blend Positively Impacts Gut Microbiota Modulation in a Randomized, Placebo-Controlled, Double-Blind Study.

11. Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineae.

12. Candida tropicalis Affects Candida albicans Virulence by Limiting Its Capacity to Adhere to the Host Intestinal Surface, Leading to Decreased Susceptibility to Colitis in Mice.

13. Beta-defensin index: A functional biomarker for oral cancer detection.

14. Time to Think Antifungal Resistance Increased Antifungal Resistance Exacerbates the Burden of Fungal Infections Including Resistant Dermatomycoses.

15. Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance.

17. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.

18. Efficacy of chlorhexidine in advanced performance technology formulation in decolonizing the skin using Candida auris skin colonization mouse model.

19. A Novel Transdermal Application for Clearing Skin Colonization by Candida auris .

20. Modulating the Microbiome for Crohn's Disease Treatment.

21. Antifungal Activity of Efinaconazole Compared to Fluconazole, Itraconazole, and Terbinafine against Terbinafine- and Itraconazole-Resistant and -Susceptible Clinical Isolates of Dermatophytes, Candida, and Mold.

22. Multiple plasma membrane reporters discern LHFPL5 region that blocks trafficking to the plasma membrane.

23. Vitamin D3 and deconvoluting a rash.

24. Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis.

25. The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy.

26. Regulation of IL-17A-Producing Cells in Skin Inflammatory Disorders.

27. Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota.

28. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).

29. GM-CSF: Orchestrating the Pulmonary Response to Infection.

30. Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.

31. Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic.

32. A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic.

33. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.

34. A region within the third extracellular loop of rat Aquaporin 6 precludes trafficking to plasma membrane in a heterologous cell line.

35. Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim.

36. In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.

37. Macrophage Response to Simulated Solar Radiation in the Development of Human Malignant Melanoma.

38. Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata .

39. Monocytes as endogenous immune sensors: Identification of inflammatory, adhesion, and mTOR-related signatures in psoriasis.

40. A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vivo Activity in a Murine Model of Hematogenously Disseminated Candida albicans.

41. A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates.

42. A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.

43. Human immunoglobulin G responses to Cimex lectularius L. saliva.

44. Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections.

45. Interaction of Resistin and Systolic Blood Pressure in Psoriasis Severity.

46. Gut microbiota and nutrient interactions with skin in psoriasis: A comprehensive review of animal and human studies.

47. Psoriasis and Psoriatic Arthritis Cardiovascular Disease Endotypes Identified by Red Blood Cell Distribution Width and Mean Platelet Volume.

48. Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.

49. An uncharacterized region within the N-terminus of mouse TMC1 precludes trafficking to plasma membrane in a heterologous cell line.

50. Human Beta Defensins and Cancer: Contradictions and Common Ground.

Catalog

Books, media, physical & digital resources